Abiomed (ABMD) Tops Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Research and development: 18.05M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 18.05M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Abiomed (NASDAQ: ABMD) reported Q4 EPS of $0.24, $0.05 better than the analyst estimate of $0.19. Revenue for the quarter came in at $94 million versus the consensus estimate of $90.52 million.
For earnings history and earnings-related data on Abiomed (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
